Glioblastoma patient-derived cell-based phenotypic drug screening and identification of possible action mechanisms through proteomic analysis

Because glioblastoma (GBM) exhibits high heterogeneity, it is desirable to use patient-derived cells from the first stage of screening for GBM drug discovery. Here, we describe a protocol to culture patient-derived GBM cells on the extracellular matrix-coated plates to allow high-throughput screenin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young Eun, Kim, Hyun Young, Jung, Daeyoung, Kang, Dukjin, Nam, Do-Hyun, Nam, Hye Jin, Cho, Heeyeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476855/
https://www.ncbi.nlm.nih.gov/pubmed/34611628
http://dx.doi.org/10.1016/j.xpro.2021.100849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476855/
https://www.ncbi.nlm.nih.gov/pubmed/34611628
http://dx.doi.org/10.1016/j.xpro.2021.100849

Ejemplares similares